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Mitochondrial dysfunction has been increasingly
linked to neurodevelopmental disorders such as intel-
lectual disability, childhood epilepsy, and autism
spectrum disorder, conditions also associated with
corticalGABAergic interneurondysfunction. Although
interneurons have some of the highest metabolic
demands in the postnatal brain, the importance of
mitochondria during interneuron development is
unknown. We find that interneuron migration from
the basal forebrain to the neocortex is highly sensi-
tive to perturbations in oxidative phosphorylation.
Both pharmacologic and genetic inhibition of adenine
nucleotide transferase 1 (Ant1) disrupts the non-radial
migration of interneurons, but not the radial migration
of cortical projection neurons. The selective depen-
dence of cortical interneuron migration on oxidative
phosphorylation may be a mechanistic pathway
upon which multiple developmental and metabolic
pathologies converge.INTRODUCTION
Mitochondrial diseases (MDs) are the most common inherited
metabolic disorder, with an estimated prevalence of 1:5,000
(Schaefer et al., 2004). Although MDs consist of a spectrum of
disorders that can involve single or multisystem presentations,
neurological symptoms are common clinical characteristics. In
recent years, clinical, genetic, and biochemical studies have re-
vealed an emerging link between mitochondrial dysfunction and
neurodevelopmental disorders, including intellectual disability
(ID) (Valenti et al., 2014), childhood epilepsy (Chevallier et al.,
2014), and autism spectrum disorder (ASD) (Rossignol and
Frye, 2012). Interestingly, these conditions have also been asso-
ciated with interneuron dysfunction (Marı´n, 2012). The correla-
tion between MDs and childhood neurological disorders raisesThis is an open access article under the CC BY-Nthe question as to whether interneuron development is particu-
larly dependent on mitochondrial function.
Recent studies have elucidated roles for mitochondria in mul-
tiple aspects of neurodevelopment including neuronal differenti-
ation (Wang et al., 2014), process outgrowth (Cheng et al., 2012;
Kimura and Murakami, 2014), and synaptogenesis (Bertholet
et al., 2013). Most of these studies have utilized glutamatergic
hippocampal neurons as a model, leaving the contribution of
mitochondria to interneuron development relatively unexplored.
Since interneurons are thought to be a key factor in the patho-
genesis of epilepsy and ASD, we were particularly interested in
examining mitochondrial behavior and function during develop-
mental processes for which there are distinct features between
glutamatergic projection neurons (PNs) and GABAergic inter-
neurons (INs) in the cortex. During development, PNs and INs
are derived from distinct locations and take different migration
routes: PNs migrate along radial glial fibers from their origin in
the dorsal ventricular zone and maintain a relatively stable
morphology oriented toward the pial surface (Noctor et al.,
2004). In contrast, cortical INs take a circuitous path from their
origin in the subcortical ganglionic eminences. Along the way,
migrating INs frequently pause, change direction, and exhibit
extensive branching dynamics of the leading process (Bellion
et al., 2005; Lysko et al., 2011, 2014; Polleux et al., 2002).
Given the greater distance and dynamic nature of IN migra-
tion, we reasoned that it requires more energy than does
the migration of PNs. First, we found that the mitochondria within
INs have a highly dynamic localization pattern during non-radial
migration. In contrast, mitochondria remain more consistently
localized in radially migrating PNs. Second, we found migrating
interneurons to be exquisitely sensitive to agents that block
the utilization of ATP generated through oxidative phosphoryla-
tion. Remarkably, glycolysis alone is insufficient for normal
IN migration but is able to support the radial migration of PNs.
Moreover, the genetic disruption ofmitochondrial oxidative phos-
phorylation (OXPHOS) in mice lacking Ant1 was associated with
dramatic alterations of IN migratory morphology and behavior,
includingmispositioningof thecentrosomes.Conversely,Ant1/
PNs appeared normal in our migration assays. These dataCell Reports 15, 229–237, April 12, 2016 ª2016 The Authors 229
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Mitochondrial Localization in Migrating Neurons
(A) Schemata of interneuron (IN; 1–3) morphologies displayed during migration.
(B) Confocal immunofluorescence (IF) images of mitochondria in migrating INs in vitro displaying varying localization patterns according to morphology.
Cytosol (GFP), mitochondria (Tom20), and nuclei (DAPI). Scale bar, 10 mm.
(C) Quantification of clustering of mitochondria in subcellular locations. Region I, trailing process (TP); II, overlapping nucleus (Nuc); III, 5 mm anterior to nucleus
(5 mm AN); IV, cytoplasmic bleb (bleb); V, leading process (LP); and VI, leading process tip (LPT). Clustering varied markedly between IN morphologies. IN
morphology 1 clustered in III (*p = 0.039). IN morphology 2 clustered in IV (*p = 0.02), while IN morphology 3 clustered in I and II (*p = 0.0343 and ***p = 0.0002).
Error bars represent median with 25th–75th percentiles ± min/max value of percent total mitochondrial area (%TMA) normalized to region’s percent of total cell
area (%TCA). n = 15 cells each type; Freidman’s test with Dunn’s correction.
(D) Schemata of pyramidal neuron (PN) migration morphology.
(legend continued on next page)
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suggest that interneuron polarity during migration is particularly
sensitive to disruptions in metabolism, and that OXPHOS is
required for normal migration of INs but not PNs. Our results
also imply that the symptomatic manifestations of mitochondrial
dysfunction and related conditions, including hypoxic injury, on
cerebral cortical function may be secondary to their selective
impact on cortical interneuron migration.
RESULTS
Mitochondria Are Highly Dynamic during Interneuron
Migration
To examine the role of mitochondria in non-radial versus radial
migration, we first sought to characterize the localization of
mitochondria in migrating INs and PNs. We classified medial
ganglionic eminence (MGE)-derived cells migrating in explant
cultures into three morphological classes corresponding to
distinct phases of their migration: leading process extension, for-
ward movement of the centrosome, and nucleokinesis/trailing
process retraction (Marı´n et al., 2006). Morphology 1 cells were
defined to have slender, tapered leading processes; morphology
2 cells have a bleb or thickening of the leading process; and
morphology 3 cells have a clear trailing process (Figure 1A).
Each subgroup displayed a distinct distribution of mitochondria
(Figure 1B). In morphology 1, mitochondria were concentrated
immediately anterior to the nucleus (Figure 1C; 49 ± 4, % total
mitochondrial area [TMA] ± SEM, 5-fold greater % TMA% total
cell area [TCA], p < 0.05) (Bellion et al., 2005; Golden et al.,
1997). In morphology 2 cells, mitochondria were concentrated
in the cytoplasmic bleb (Figure 1C; 71 ± 2, %TMA ± SEM,
3.9-fold greater %TMA/%TCA than other areas, p < 0.05), while
in morphology 3, the mitochondria were aggregated in the trail-
ing process and posterior nuclear area (Figure 1C, 29 ± 4, %
TMA ± SEM, 39% ± 5 TMA ± SEM respectively, 1.7-fold greater
%TMA/%TCA than other areas, p < 0.05) (Bellion et al., 2005).
Although these independent clustering behaviors have been
noted in the literature, mitochondrial dynamics during migration
have not been studied. To evaluate the subcellular localization of
mitochondria in relation to the morphological migratory phases,
we next performed time-lapse imaging of fluorescently labeled
mitochondria in migrating interneurons. Interestingly, mitochon-
dria displayed consistent positional reorganization during migra-
tion, as their subcellular location changed in concert with the
morphology of the migrating cell (Figures 1G and 1H; Movie
S1). The mitochondrial localization and changes in location
observed in the three IN morphologies were confirmed by live(E) Confocal IF images of mitochondria in representative migrating PN. Cytosol (
(F) Quantification of clustering mitochondria in migrating PNs. Region I: TP; II: Nu
*p = 0.0327, **p = 0.0064, and ****p < 0.0001. n = 15 cells; Freidman’s test with
(G) Time-lapse imaging of a migrating Dlx5/6CIG IN in vitro (cytosol, GFP; mitochon
1 frame = 10 min. Scale bar, 10 mm. See also Movie S2.
(H) Quantification of INs displaying a extensive movement of mitochondrial th
compartment. The majority of INs showed this movement of mitochondria throu
cultures, 200 cells. Values represent mean ± SEM.
(I) Live time-lapse imaging of a migrating PN (cytosol, GFP; mitochondria, MitoD
(J) Quantification of PNs movement of mitochondrial through the cell versus tho
movement of mitochondria through PNs was essentially not observed. p = 0.
mean ± SEM.imaging of mitochondria in whole-brain-slice cultures from em-
bryonic day 13.5 (E13.5) embryos (Figure S1; Movie S2). The
localization of mitochondria in migrating INs was ranked accord-
ing to morphology as matching or not matching the localization
observed in migrating dissociated INs and found to be highly
correlated (Figure S1A).
In contrast tomigrating INs,migrating PNsmaintain a relatively
consistent migratory morphology after leaving their multipolar
phase in the ventricular and subventricular zones (Figure 1D
and 1I) (Noctor et al., 2004). During radial migration in the cortical
plate, mitochondria were found primarily anterior to the nucleus
and in the leadingprocess, showing little change in regional local-
ization (Figures 1E, 1F, 1I, and 1J; Movie S3). These data reveal
that the intracellular position, and changes in location, of mito-
chondrial of INs and PNs are clearly distinguishable and suggest
that there may be differences in energy requirements between
these two neuronal cell populations during development.
Oxidative Phosphorylation Is Necessary for Normal IN
Migration, but Not for Radial Migration
To determine whether migrating INs and PNs have distinct ener-
getic requirements, we studied their need for mitochondrially
generated ATP in explant and slice cultures. Cells generate
ATP through glycolysis in the cytosol and oxidative phosphoryla-
tion (OXPHOS) in the mitochondria. To test whether OXPHOS is
necessary for normal neuronal migration, we examined cell
movement after blocking OXPHOS with either oligomycin or
bongkrekic acid (BA). Oligomycin (Olig) blocks mitochondrial
production of ATP by inhibiting the ATP synthase (Kulka and
Cooper, 1962), while BA prevents the translocation of ATP
across the inner mitochondrial membrane by inhibiting the
adenine nucleotide translocator isoforms 1 (Ant1, also known
as Slc25a4) and 2 (Ant2 also known as Slc25a5) (Henderson
and Lardy, 1970). IN migration was exquisitely sensitive to Olig
treatment, where 0.02 mM reduced IN migration by 78% (Fig-
ure S2A; Movie S4). Treating INs with 2.5 mM BA reduced IN
migration by 50% (p% 0.001) (Figure 2A; Movie S5). These cells
showed no reduction in somal translocation (Figure 2C; not sta-
tistically significant but trending toward slower) but a significant
increase in the time spent paused (Figure 2D). Interestingly,
treated cells exhibited elongated trailing processes (Figures 2B
and 2F) as well as a higher frequency of trailing processes (Fig-
ure 2E) and for more time (Figure 2G) than controls. Furthermore,
at low BA concentrations, migrating INs exhibit a 10-fold in-
crease in direction changes (Figure 2H). BA also resulted in sig-
nificant reduction in the leading process length (Figure 2I). TheGFP), mitochondria (MitoDsRed), and nuclei (DAPI). Scale bar, 10 mm.
c; III: 5 mm AN; IV: cytoplasmic bleb (bleb); V: LP; VI: leading process tip LPT.
Dunn’s correction.
dria, MitoTracker Red CMXRos) show intracellular movement of mitochondria.
rough the cell versus those where the mitochondria remain confined to one
ghout the cell during migration. p < 0.0001, unpaired t test, n = 5 independent
sRed). 1 frame = 10 min. Scale bar, 10 mm. See also Movie S3.
se where the mitochondria remain confined to one compartment. Intracellular
002, Mann-Whitney, n = 6 independent cultures, 82 cells. Values represent
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Figure 2. Pharmacological Inhibition of
OXPHOS Reduces IN Migration
(A) MGE explants were cultured in high
glucose ± BA, an inhibitor of OXPHOS. Inhibiting
OXPHOS decreased IN migration. (BA con-
centration: 0 mM and 0.5 mM = 0.36 ± 0.4;
2.5 mM = 0.18 ± 0.02, 5 mM = 0.09 ± 0.01; all in
mm/min ± SEM; 0 versus 2.5 or 5, p % 0.001,
n = 5 independent cultures, >150 cells each,
ANOVA test).
(B) Representative phase image of BA-treated
MGE INs. Arrows identify elongated trailing pro-
cesses. Scale bar, 50 mm.
(C) Somal translocation was calculated for
each migrating IN; while slightly slower, this
did not reach significance (BA concentration:
0 mM = 0.53 ± 0.04; 2.5 mM = 0.45 ± 0.01; all in
mm/min ± SEM; p % 0.075, n = 5 independent
cultures, > 150 cells each, unpaired t test,
Welch’s correction).
(D) The time a migrating neuron was paused
versus moving was also calculated. In the pres-
ence of BA, the neurons spend significantly
more time paused compared to control cells
(BA concentration: 0 mM = 0.30 ± 0.05; 2.5 mM =
0.59 ± 0.05; all in total time paused/imaging
period ± SEM; p % 0.002, n = 5 independent
cultures, > 150 cells each, unpaired t test, Welch’s
correction).
(E–G) In addition to decreased migration, inhibi-
tion of OXPHOS increased the frequency (E; p <
0.001, unpaired t test with Welch’s correction,
mean ± SEM), length (F; p < 0.0001, Mann Whit-
ney, median with interquartile range ± min/max),
and life of trailing processes (G; p < 0.0001, Mann-
Whitney). For each, n = 5 independent cultures,
100 cells each.
(H) OXPHOS inhibition also causes increases in
direction changes (the mean number of direction
changes/hour ± SEM was 0.024 ± 0.006 for 0 mM
BA; and 0.23 ± 0.05 for 2.5 mM BA, p < 0.0001;
n = 5 independent cultures, 100 cells each, un-
paired t test with Welch’s correction).
(I–K) Leading process length (I), branches/cell
(J), and branch length (K) were all signifi-
cantly reduced in migrating INs treated with
BA when compared to controls (p < 0.0001, p <
0.001, and p < 0.0001, respectively, Mann-Whit-
ney test).
(L) Sample migration paths of INs (yellow) and PNs
(red) in E16 brain slices treated with vehicle or 20 mM BA. See also Movie S5. CP, cortical plate; IZ, intermediate zone; VZ, ventricular zone. Scale bar, 150 mm.
(M) IN migration rates decreased in slices treated with BA (p = 0.0023, n = 6 individuals, 20 INs each) whereas PNs were unaffected (p > 0.05, n = 6 individuals,R
15 PNs in each). Unpaired t test with Welch’s correction, mean ± SEM.leading processes also branched less frequently and the branch
lengths were significantly reduced (Figures 2J and 2K).
To determine whether OXPHOS is sufficient to supply energy
for IN migration, we removed glucose (GLUC) from the medium
or inhibited glycolysis with 2-deoxyglucose (2-DG) and pro-
vided the OXPHOS substrate pyruvate (PYR). Alternatively,
we substituted GLUC for galactose (GAL). GLUC deprivation
reduced migration by 53% (Figure S2C), while inhibition with
2-DG reduced migration by 68% (Figure S2C). When INs are
supplemented with PYR or GAL, ATP generation is dependent
on OXPHOS alone (Adeva-Andany et al., 2014; Marroquin232 Cell Reports 15, 229–237, April 12, 2016et al., 2007). Both PYR and GAL were sufficient to fully rescue
IN migration under conditions of glycolysis inhibition, and this
ability to sustain migration was abrogated with addition of sub-
threshold doses of BA (Figure S2C). Therefore, OXPHOS is
both necessary and sufficient for normal IN migration.
The requirement for OXPHOS in neuronal migration was
further tested using slice cultures where both non-radially
migrating INs, and radially migrating PNs, could be studied
simultaneously. We utilized Dlx5/6CIG mice in which the INs are
genetically labeled with EGFP. At E14, a DsRed expression
construct was electroporated into Dlx5/6CIG embryos to label
Figure 3. Interneuron Migration Is Reduced
in Embryonic Ant1 Mutants
(A) At E13.5 migrating INs (labeled by calbindin
immunohistochemistry) have not traveled as far in
Ant1/ brains compared to Ant+/+ brains. The
white arrow indicates the leading migrating INs.
Ant1+/+servedas thestandardizedcontroldistance
of 1.0 ± 0.02 with Ant1/ IN migration showing on
average 0.85 ± 0.02 relative distance units ± SEM
or a 15% reduction, p < 0.0001. Scale bar, 200 mm.
(B)Quantificationof relativedistanceof leading cells
ofmigrating INs. ****p < 0.0001, n = 5 individuals, 25
cells each, Mann-Whitney test. Values represent
median with interquartile range ±min/max.
(C) Quantification of relative INs in cortex ;
Ant1+/+ = 1.0 ± 0.06; Ant1/ = 0.7 ± 0.04;
normalized INs in cortex ± SEM, **p = 0.004, n = 5,
unpaired t test with Welch’s correction.
(D) Ant1/ INs in the cortex have increased
trailing process (TP) length. Ant1+/+: 1.1 mm ± 0.3;
Ant1/: 5.2 mm ± 1.1 (±SEM), *p = 0.022, n = 5
individuals, 25 cells each, unpaired t test with
Welch’s correction.
(E) Proliferation in germinal ventricular zone (VZ),
indicated by Ki67 immunostaining, was not
impacted by loss of Ant1. Medial ganglionic
eminence (MGE) and pallium (Ctx). Ant1+/+ versus
Ant1/ for each region, p = 0.286 for MGE, p =
0.309 for Ctx; n = 5 individuals, unpaired t test with
Welch’s correction.
(F) Loss of Ant1 did not increase cell death, indi-
cated by caspase-3, in the MGE and the ventral
and dorsal pallium (V/D Ctx). Ant1+/+ versus
Ant1/ for each region, p > 0.99, n = 5 in-
dividuals, Kruskal-Wallis, Dunn’s correction.
Values represent median, 25th–75th percentile ±
min/max.
(G) INs in cortex of Ant1/ mice displayed abnormal leading process orientation. Arrowheads indicate misaligned INs. Scale bar, 75mm.
(H) Quantification of cortical IN leading process orientation into quadrants: Q1, dorsal; Q2, pial; Q3, ventral; and Q4, ventricular orientation. The average percent
of IN oriented in Q1 for Ant1+/+ was 80 ± 4 and 50 ± 4; Ant1/ (±SEM), ****p = 0.0001 and **p = 0.0069, n = 5, ANOVA with Sidak’s correction.the progenitors of radially migrating PNs. Embryos were har-
vested at E16, and cortical slices from individuals were treated
with BA. Remarkably, BA treatment reduced IN migration rates,
whereas PNs were unaffected (Figures 2L and 2M; Movie S6;
IN: 0.289 ± 0.06 mm/min decrease, p < 0.002; PN: 0.03 ±
0.02 mm/min increase, p > 0.1). These data demonstrate that
the non-radial migration of cortical interneurons is dependent
onOXPHOS, while the radial migration of cortical projection neu-
rons is either not or minimally OXPHOS dependent.
Selective Disruption of Non-radial IN Migration in Ant
1/ Mutants
Wenext sought to corroborate our pharmacologic data of the dif-
ferential effects of OXPHOS on PN versus IN migration in mice
lacking the Ant1 isoform. The genetic removal of Ant1 reduces
the ATP flux from themitochondria to the cytosol, andAnt1 is ex-
pressed in cortical neurons, including INs (Figures S3A and S3B;
Graham et al., 1997; Lee et al., 2009; Levy et al., 2000).
To determine if loss of Ant1 disrupts IN migration in vivo,
Ant1+/+ and Ant1/ brains were sectioned and stained for cal-
bindin at E13.5 to detect a subset of migrating INs. On average,
the leading edge of INs from wild-type brains migrated 15%percent farther than that of Ant1/ brains (Figures 3A and 3B),
and there was a 30% decrease in total migrating INs invading
the cortex in Ant1/ animals (Figure 3C). Additionally, Ant1/
migrating INs displayed aberrant orientation of the leading pro-
cess with 30% fewer cells oriented in the main migration path
(Figures 3G and 3H). Interestingly,Ant1/ INs had longer trailing
processes in vivo (Figure 3D), a characteristic also seen in wild-
type INs treated with BA in vitro (Figure 2C). Neither proliferation
nor cell death in the MGE or cortex was impacted by loss of
Ant1/ (Figures 3E and 3F), excluding these mechanisms as
an explanation for the reduction of cells in the mutant cortex.
This suggests that a migration phenotype is the primary cause
for the IN defect in Ant1/ embryonic cortex.
Toconfirm theeffectofAnt1deficiencyon INmigration,Ant1/
MGE explants were assayed. Ant1/ INs migrated shorter dis-
tances (40% decrease; Figures 4A and 4B), and more slowly
(42%decrease;Figure 4C)whencompared toAnt1+/+ INs. Inter-
estingly, Ant1/ IN migration was exquisitely sensitive to BA
treatment, showing large reductions in INmigration rates at doses
that hadnoeffect onAnt1+/+ cells (Figures 4C), likely due to further
blocking ofmitochondrial ATP efflux through inhibition of theAnt2
isoform (Graham et al., 1997; Levy et al., 2000).Cell Reports 15, 229–237, April 12, 2016 233
Figure 4. Abnormal Migration by Ant1/
Interneurons
(A) MGE explants were cultured in vitro for 16 hr.
Ant1/ INs did not migrate out of the explant as
far as controls.
(B) Quantification of relative distance of IN migra-
tion from explant showing a statistically significant
difference in the distance migrated between
Ant1/ and Ant1/ INs., Ant1+/+ is calculated as
the normalized distance (1.0 ± 0.03) and Ant1/
was on average approximately 40% reduced
(0.61 ± 0.08); normalized distance ± SEM. **p =
0.0034, n = 6, 50 cells each genotype, unpaired t
test with Welch’s correction. Scale bar, 250 mm.
(C) Quantification of INmigration rates of wild-type
and mutant INs. Ant1/ IN migration rates had
slower migration rates (****p < 0.0001) and were
more sensitive to BA treatment compared to
Ant1+/+(****p < 0.001). Migration rates Ant1+/+:
0.42 ± 0.01; Ant1/: 0.24 ± 0.01; mm ± SEM, n =
5, 150 cells each condition, ANOVA with Bonfer-
onni’s correction.
(D) Examples of migration path of GFP+ INs in slice
culture (also see Movie S7). Dots, start; lines,
paths. Scale bars, 150 mm.
(E) Ant1/ INs in slices display decreased
migration rates relative to control. The relative
migration rate was compared between Ant1+/+:
0.94 ± 0.04 and Ant1/: 0.65 ± 0.04; relative
migration rate ± SEM, ****p < 0.0001, n = 5, un-
paired t test with Welch’s correction.
(F) Ant1/ INs display increased direction
changes. Ant1+/+: 0.07 ± 0.01; Ant1/: 0.25 ±
0.02; direction changes per cell/hr ± SEM, p <
0.0001, n = 5, unpaired t test with Welch’s
correction.
(G) Frequency plot of IN direction changes; dark
gray = Ant1+/+, light gray = Ant1/. ****p < 0.0001
and ***p = 0.0006, n = 5, two-way ANOVA with
Sidak’s correction.In contrast to the clear defects in IN migration, Ant1/ PN
migration was normal. E14.5 embryos were electroporated
with pCAG-IG and cell positions assayed on E18.5. The loss of
Ant1 did not alter radial migration (Figures S3A and S3B). To
further assay the migration of PNs, we injected 5-ethynyl-2’-de-
oxyuridine (EdU) to pregnant dams on E14.5 and harvested the
embryos on E18.5. Labeling for EdU (E14.5 injections mainly la-
bel outer layer neurons) and Tbr1 (a deeper layer neuronal
marker) showed normal positioning of cortical neurons between
Ant1+/+ and Ant1/ brains (Figure S4C). Together, these data
indicate that in marked contrast to the non-radial migration of
cortical INs, Ant1 does not appear to affect the radial migration
of PNs.
Loss of Ant1 Alters Centrosome Localization in
Migrating Interneurons
To further examine the migration behaviors disrupting IN migra-
tion in Ant1/ mutants, we crossed these mice to Dlx5/6CIG
mice to genetically label forebrain GABAergic neurons. Live im-234 Cell Reports 15, 229–237, April 12, 2016aging of slices from Ant1/ and littermate Ant1+/+ controls re-
vealed an 31% decrease in migration rates of GFP+ cells in
the cortex (Figure 4E) and 3.6-fold increases in direction
changes (Figures 4D, 4F, and 4G; see also Movie S7). These
data suggest an impaired ability of Ant1/ INs to maintain po-
larity. To study this further, we examined centrosome localiza-
tion in MGE explant cultures. In control INs, the centrosome lo-
calizes anterior to the nucleus or in the bleb of the leading
process. Ant1/ INs displayed markedly aberrant centrosome
positions, posterior to the leading edge of the nucleus, or even
behind the nucleus (Figures 5A and 5B). To confirm this finding,
we also assayed the localization of centrosome after BA.
Similar to the findings in the Ant1/, BA-treated migrating
INs also displayed a significant posterior positioning of the
centrosome (Figures 5C and 5D). Taken together with the
increased direction changes seen after either genetic or
biochemical impairment in mitochondrial energetics, these re-
sults suggest that IN polarity is particularly sensitive to mito-
chondrial perturbation.
Figure 5. Loss of Ant1 Causes a Shift in Centrosome Position
(A and C) Sample images of centrosome position in INs show mislocalized
centrosome in Ant/ INs (A) and BA-treated INs (C) in vitro. Gamma-tubulin,
red; nucleus, blue; cytoplasm, green. Scale bar, 15 mm.
(B and D) Scatterplot of centrosome score of Ant/ (B) and BA-treated (D) INs
(gray lines, average nuclear length). Ant1+/+: 0.06 ± 0.01; Ant1/: 0.02 ± 0.01;
centrosome score ± SEM; p = 0.0005, n = 75 cells each genotype, Mann-
Whitney test, median with interquartile range ± min/max.DISCUSSION
Our results reveal that migrating INs and PNs display major dif-
ferences in mitochondrial localization. During IN migration, mito-
chondrial localization is highly dynamic, with the highest density
ofmitochondria appearing tomove between the posterior trailing
process, the region anterior to the nucleus, and the cytoplasmic
bleb. In contrast, during PNmigration, mitochondria are primarily
restricted to the region anterior to the nucleus. We also found
that inhibition of OXPHOS drastically decreased the migration
rates of INs, but not PNs. These findings suggest that INs, unlike
radially migrating PNs, are highly dependent on mitochondrial
ATP production. The reduced migratory rates and increased
direction changes by INs also suggest that the maintenance of
polarity is an energetically vulnerable process and is required
for normal IN development. These data link mitochondrial func-
tion to the prenatal development of a critical cerebral cortical
neuronal subpopulation.
Few studies have addressed mitochondrial localization and
trafficking in migrating neurons. Previous work has shown that
Lis1, Tau 1, and DCX, genes that cause defects in radial migra-tion and IN development, cause mislocalized and altered mito-
chondrial trafficking (Khalaf-Nazzal et al., 2013; Sapir et al.,
2012; Yamada et al., 2009). Although this suggests that defects
in mitochondrial localization may also impact PNs, each of
these genes also regulates microtubule dynamics. Thus, in these
models, it is unclear whether changes in mitochondrial localiza-
tion contribute to the defects in radial migration or whether these
genes have a direct impact on mitochondrial function. Our data
address this issue by investigating mitochondrial localization in
both PN and IN populations and by interfering directly with mito-
chondrial function. Although mitochondrial dysfunction in addi-
tion to other defectsmay contribute to abnormal radial migration,
we provide clear evidence that INs are much more sensitive to
OXPHOS deficits.
Mitochondrial contribution to neuronal metabolism has been
largely studied in the context of the adult nervous system,
focused on how loss of mitochondrial function results in neuro-
degeneration and cell death. Recent data have emphasized
the importance of mitochondrial energetics in basic neurophys-
iology. For example, mitochondrial energetics are essential for
interneuron regulation of gamma oscillations that are themselves
associated with cognitive functions (Kann et al., 2014). However,
few data exist on the earlier developmental requirements for
mitochondrial OXPHOS. Several studies have indicated that
regulation of mitochondrial metabolism impacts neurogenesis
and differentiation (Bertholet et al., 2013; Wang et al., 2014),
but the requirement for OXPHOS during neuronal migration
had not been studied. Surin et al. suggested that glycolysis is
a primary driver of embryonic neuronal metabolism of hippo-
campal cultures (Surin et al., 2012). Since interneurons comprise
only6% of the neurons in hippocampal cultures (Benson et al.,
1994), it is likely the measurements in this study were primarily
representative of pyramidal neuron metabolism. This lack of
active OXPHOS in embryonic pyramidal cells thus compliments
our findings that PN migration is not impacted by OXPHOS inhi-
bition. Our data clearly show that interneuron migration required
OXPHOS and suggest that distinct neuronal populations have
different metabolic requirements during development.
We found that Ant1mutant INs exhibit changes in centrosome
localization, increased length of the trailing process, and
increased direction changes during IN migration. Mitochondria
have been implicated in centrosome homeostasis in mitotic cells
(Donthamsetty et al., 2014). Additionally, the mislocalization of
centrosomes has also been observed in mice lacking mDia1
and 3, proteins of the formin family that regulate cytoskeletal dy-
namics via Rho-GTPases (Daou et al., 2014). Interestingly, IN
migration is disrupted in these mutants, but radial migration is
not (Shinohara et al., 2012). In this model, focus was on subven-
tricular zonemigration of interneurons to the olfactory bulb; thus,
it is unclear whether there are additional phenotypic similarities
exist between these models. The similarities in our phenotype
and selective effect on INs suggest that the regulation of centro-
somal position and actinomycin contractions within the trailing
process are energetically vulnerable processes and warrant
further investigation.
Patients with ASD, and particularly those with combined ASD,
ID, and epilepsy, commonly have evidence of mitochondrial
dysfunction (Rossignol and Frye, 2012). The manner by whichCell Reports 15, 229–237, April 12, 2016 235
mitochondrial dysfunction contributes to these phenotypes is
generally attributed to a deficiency in meeting ongoing neuronal
metabolic demands or increased free radical production result-
ing in cell death. Our data provide clear evidence for a final com-
mon pathway into the pathogenesis of ASD, developmental ep-
ilepsies, and IDs. These clinical phenotypes associated with
mitochondrial disorders may not solely arise from energetic def-
icits or the formation of free radicals during later neuronal func-
tion but may be secondary to abnormal IN development.
EXPERIMENTAL PROCEDURES
Mouse Strains
CD1 or Dlx5/6CIG (Stenman et al., 2003) and Ant1/ mice on a C57BL6/NJ
(Ronchi et al., 2013) of both sexes were used as indicated. The Institutional
Animal Care and Use Committee at the Children’s Hospital of Philadelphia
(Philadelphia, PA) approved all studies.
Brain Explant and Slice Cultures
Explant and slice cultures were generated from the indicated embryonic day
mouse pups as previously described (Lysko et al., 2011, 2014).
Treatment Protocols
For inhibition of oxidative phosphorylation, explants were cultured for 24 hr in
Dulbecco’smedia (DM) with 35mMglucose. Immediately prior to imaging, me-
dia was exchanged with DM with PBS vehicle, Oligo (Sigma), or BA (Enzo Life
Sciences).We foundastraindifference in response to treatment toBA.CD1cells
were treatedwith 0.5, 2.5, 5, and50mMBA,whileAnt1+/+andAnt1/ cellswere
treated with 0.5 fM BA. For glucose deprivation and inhibition experiments, ex-
plantswere cultured for 24hr in glucose-freeDMEM (Invitrogen) plusN2supple-
ment (Gibco)with orwithout 10mMsodiumpyruvate (Sigma) or 5mMgalactose
(Sigma), ± 2.5 mMBA. For treatment with 2-DG, explants were cultured for 24 hr
with5mMglucoseDMsupplementedwith 500mM2-DG (Sigma),withorwithout
10 mM sodium pyruvate or 5 mM galactose ± 0.5 mM BA.
Histology and Immunocytochemistry
Brains of E13.5, E16, or E18.5 embryos were processed for histology and
immunohistochemistry as previously described (Lysko et al., 2011). Primary
antibodies used included anti-calbindin D-28k (rabbit; Swant, 1:1,000),
caspase-3 (rabbit; Abcam, 1:500), Ki67 (rabbit; Neomarkers, 1:300), anti-
Tom-20 (rabbit; Santa Cruz Biotechnology, 1:500), and anti-GFP (chicken:
Invitrogen, 1:2,000). Secondary antibodies included goat anti-rabbit-biotin
(Vector Laboratories) followed by Streptavidin/Alexa Fluor 594 (Invitrogen) or
anti-rabbit-Alexa Fluor 594 (Invitrogen) anti-chick-Alexa 488 (Invitrogen), all
at 1:2,000. Nuclei were counterstained with DAPI.
MGE explants were fixed and immunolabeled as previously described (Ly-
sko et al., 2011, 2014) using anti-Tuj1 (rabbit; Neuronal CIII b-tubulin; Covance,
1:1,000), anti gamma-tubulin (mouse; Sigma, 1:200), anti-GFP (chicken; Invi-
trogen, 1:200), or anti-Ant1 (rabbit) as primary antibodies.
Intrauterine Electroporations
Embryos at either E14 or E14.5 were electroporated in utero as previously
described (Nasrallah et al., 2012) with the following constructs: pCAG-IG
(Addgene 11150; 2 mg/ml), pCAG-DsRed (Addgene 11151; 2 mg/ml), pDsRed2-
mito (MitoDsRed;Clontech632421;0.5mg/ml). Formarkingmitochondria in radi-
allymigrating neurons and sliceBA treatments, embryoswere electroporated at
E14 and harvested 48 hr later. For assessing radial migration, embryos were
electroporated at E14.5 and harvested at E18.5.
Live Marking of Mitochondria In Vitro
To image mitochondria in migrating INs, explants from Dlx5/6CIG embryos
were cultured for 24 hr. Prior to imaging, cells were treated with 100 nM Mito-
Tracker Red CMXRos (Invitrogen) for 30 min in Opti-MEM (Invitrogen) with
10 mM glucose. Cells were then rinsed with PBS and supplied with fresh
DM before imaging.236 Cell Reports 15, 229–237, April 12, 2016Microscopy
For all experiments, time-lapse images were acquired at indicated intervals for
a minimum of 6 hr with an Olympus Fluoview (FV10i) confocal microscope at
37C, 5% CO2. Magnifications were as follows: 103 magnification with 23
zoom for treatment protocols at 5-min intervals, and 103 magnification in sli-
ces at 10-min intervals. For higher resolution, 603magnification was used for
acquiringmitochondrial localization inmigration INs at 10-min intervals. For sli-
ces, z stacks of 10 mm each were taken, capturing the full range of detectable
GFP+ cells or DsRed cells within the slice. Slices were imaged for aminimum of
5 hr. Images of fixed explants cells and slices were taken on an Olympus Fluo-
view (FV10i) confocal microscope at 203 magnification. Mitochondria were
localized within individual cells from 40-mm floating brain slices by collecting
1.5-mm z stacks in using the Olympus Fluoview (FV10i) confocal microscope
at 603 magnification. Mitochondria were labeled with Tom20, and EGFP,
driven by the Dlx5/6 promoter, was detected with the anti-GFP antibody. Im-
ages of calbindin-stained slices and were taken at 53 and 103 magnification
every 5 mm for 15 mm on a Leica CTR600 fluorescent microscope.
Quantification
In all experiments, cells were selected at random using ImageJ’s grid plugin for
all experiments unless indicated otherwise. The color-profiler ImageJ plugin
was used to generate plots of fluorescence units. For fixed cells, mitochondrial
area was calculated by thresholding images using ImageJ’s auto-local thresh-
olding plugin (for invitro culture, Bernsen method, 15 pixels) or by color thresh-
olding images for overlapping green and red pixels (for cells in fixed slices).
Thresholded images were analyzed using the particle analyzer plugin to calcu-
late mitochondrial area in subcellular regions. Distance of migration along the
cortex of the 25 leading cells was measured as a percentage of the distance
between the striatocortical notch and dorsal cortical curve and normalized
to the average distance of wild-type littermates. Relative migration distance
for explants was calculated from the explant edge to the position of the ten
cells that had migrated the furthest. Values were normalized to averages of
Ant1+/+ littermates. Cell migration speed was calculated as previously pub-
lished (Lysko et al., 2011). Leading process orientation was calculated by
designating cells into quadrants based on the orientation of their leading pro-
cesses. Centrosome scores were determined by defining the anterior edge of
the nucleus as zero and centrosomes positioned behind the leading edge of
the nucleus as negative values. Centrosome position was measured from
the posterior of the cell and represented as a percent of total cell length.
Statistics
Prism 6 software was used for all statistical analysis. Data were tested for
normality using either the Kolmogorov-Smirnov test or the D’Agostino and
Pearson omnibus normality test. If the data were not normal, non-parametric
analysis was utilized. p < 0.05 were considered significant. All values are pre-
sented as mean ± SEM unless otherwise indicated.
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